Evaluation of Clinical Perfectionism in Parkinson Disease
EPMP-1
2 other identifiers
interventional
60
1 country
1
Brief Summary
Scientific studies show that almost half of the people with Parkinson's Disease (PD) suffer of depression and / or anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Oct 2014
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2014
CompletedStudy Start
First participant enrolled
October 6, 2014
CompletedFirst Posted
Study publicly available on registry
July 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedAugust 21, 2018
August 1, 2018
3.8 years
April 22, 2014
August 20, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Perfectionism evaluation 1
Scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS)
Day 0
Perfectionism evaluation 2
Hewitt Multidimensional Perfectionism Scale (HMPS).
Day 0
Secondary Outcomes (2)
Depression and anxiety evaluation 1
Day 0
Depression and anxiety evaluation 2
Day 0
Study Arms (2)
Parkinsonian
OTHERPatient Arm: Parkinsonian will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Dystonic
OTHERComparator Arm: Dystonic patient will complete several scale of evaluation. Behavioral: Completion of scales evaluation
Interventions
Patient complete scores to perfectionism scales (Frost Multidimensional Perfectionism Scales (FMPS), Hewitt Multidimensional Perfectionism Scale (HMPS), scores to depression scale (Beck Depression Inventory (BDI)) and anxiety scale (State Trait Anxiety Inventory (STAI))
Eligibility Criteria
You may qualify if:
- Age greater than 18 years
- Score Mini Mental Scale (MMS) greater than 23
- For Parkinsonian, Parkinson disease be defined according to the criteria of the Unified Parkinson Disease Rating Scale (UPDRS), with a Hoehn and Yahr stage 1, 2 or 3
- The control patients present dystonias not within the scope of Parkinson
- Informed Consent Form signed
- Patient covered by social insurance
You may not qualify if:
- Proven Presence of neuropsychological disorders
- Patients with deep brain stimulation
- Diagnosis of somatic pathology diagnosed
- Private Patient freedom or protected adult (under guardianship)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens
Amiens, 80054, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre KRYSTKOWIAK, MD, PhD
CHU Amiens
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2014
First Posted
July 6, 2016
Study Start
October 6, 2014
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
August 21, 2018
Record last verified: 2018-08